Research & Development
Mastering modified-release performance: excipient considerations
Imagine a world where enhanced therapeutic efficacy, improved patient compliance and reduced adverse effects are tangible outcomes — even for drugs with short pharmacokinetic...
Tabletability, compactability and compressibility: What’s the difference?
To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
Indian government bans three medicines owing to health risks
Decision follows strong stand on suspending marketing of all drugs prohibited for sale in other countries, including the US, UK, EU and Australia
Resolving capping issues in tablet manufacturing
Natoli explores the various causes of capping and the methods to prevent it
Causes and solutions for dark spots in tablet manufacturing
Natoli Engineering examines the causes and solutions for dark spots that can halt production
21-22 February 2024 | Exhibition | Birmingham, UK
Lonza and Vertex open transformative cell therapy facility
The companies have opened a manufacturing facility in Portsmouth, New Hampshire, to accelerate the development of cell therapies for type 1 diabetes
GlobalData publishes analysis of top 25 global pharma companies
The data and analytics company has tracked the market cap performance of the top 25 pharma companies for the quarter ending 31 March, 2018 compared to 2017 revealing a number of interesting insights
Talking continuous: Q&A with Patricia Hurter from Vertex
How innovative drug manufacturer Vertex is achieving continuous manufacturing in pharmaceutical development and production
GlobalData names top 25 global pharma companies by market cap
The performance highlights of the top 25 publicly traded global pharma companies for the year 2017 have been confirmed in the latest research from GlobalData